Non‐muscle invasive bladder cancer and bacillus Calmette‐Guerin treatment: a review of the literature

E-ISSN： 1749-771x|9|2|57-68

ISSN： 1749-7701

Source： INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol.9, Iss.2, 2015-07, pp. : 57-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical Bacillus Calmette-Guerin Therapy for Grade 3 Non-Muscle Invasive Bladder Cancer: Results of Six or Eight Successive Instillations

Current Urology, Vol. 5, Iss. 1, 2011-03 ,pp. : 41-45

Karger

Access to resources Recommend Favorite

The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 46-50

Karger

Access to resources Recommend Favorite

Contemporary cost‐effectiveness analysis comparing sequential bacillus Calmette‐Guerin and electromotive mitomycin versus bacillus Calmette‐Guerin alone for patients with high‐risk non–muscle‐invasive bladder cancer

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2424-2431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer

Current Urology, Vol. 6, Iss. 3, 2012-12 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Intravesical bacillus Calmette–Guérin instillation in non‐muscle‐invasive bladder cancer: A review

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 18-24

John Wiley & Sons Inc

Access to resources Recommend Favorite